We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+4.38%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$56.3B
AUM Growth
-$596M
Cap. Flow
-$1.62B
Cap. Flow %
-2.89%
Top 10 Hldgs %
32.29%
Holding
1,743
New
37
Increased
427
Reduced
443
Closed
34

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$374M
2
MSFT icon
Microsoft
MSFT
+$253M
3
AAPL icon
Apple
AAPL
+$200M
4
AVGO icon
Broadcom
AVGO
+$198M
5
META icon
Meta Platforms (Facebook)
META
+$193M

Sector Composition

Rank Sector Weight
1 Technology 29.94%
2 Financials 13.84%
3 Healthcare 12.35%
4 Consumer Discretionary 10.61%
5 Communication Services 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
301
Cummins
CMI
$89B
$22.1M 0.04%
63,431
+31,662
+100% +$11.1M
CDNS icon
302
Cadence Design Systems
CDNS
$95.5B
$22M 0.04%
73,347
-45,238
-38% -$13.2M
VMC icon
303
Vulcan Materials
VMC
$37.3B
$21.9M 0.04%
85,120
-880
-1% -$237K
CNC icon
304
Centene
CNC
$31.5B
$21.9M 0.04%
360,745
-146,002
-29% -$9.1M
VEEV icon
305
Veeva Systems
VEEV
$32.7B
$21.7M 0.04%
103,335
+40,073
+63% +$8.81M
RMD icon
306
ResMed
RMD
$30.4B
$21.7M 0.04%
94,909
-211
-0.2% -$50.8K
TER icon
307
Teradyne
TER
$49.6B
$21.6M 0.04%
171,507
+94,699
+123% +$11.2M
EPAM icon
308
EPAM Systems
EPAM
$5.21B
$21.5M 0.04%
92,058
-17,184
-16% -$3.82M
DXCM icon
309
DexCom
DXCM
$29B
$21.3M 0.04%
274,500
-3,813
-1% -$282K
VLTO icon
310
Veralto
VLTO
$24B
$21.2M 0.04%
208,363
+1,322
+0.6% +$141K
ROST icon
311
Ross Stores
ROST
$80.6B
$21.2M 0.04%
140,267
-31,380
-18% -$4.61M
WAT icon
312
Waters Corp
WAT
$37.9B
$21.2M 0.04%
57,183
+37,234
+187% +$13.6M
SRPT icon
313
Sarepta Therapeutics
SRPT
$1.61B
$21.1M 0.04%
173,491
-51,837
-23% -$6.35M
PSA icon
314
Public Storage
PSA
$62.3B
$20.7M 0.04%
69,225
-5,393
-7% -$1.79M
PEN icon
315
Penumbra
PEN
$12.6B
$20.6M 0.04%
86,912
-39,966
-31% -$9.09M
HLT icon
316
Hilton Worldwide
HLT
$73.3B
$20.6M 0.04%
83,311
-5,622
-6% -$1.38M
PHAT icon
317
Phathom Pharmaceuticals
PHAT
$931M
$20.5M 0.04%
2,527,054
-54,334
-2% -$673K
CMG icon
318
Chipotle Mexican Grill
CMG
$42.9B
$20.5M 0.04%
339,759
+22,589
+7% +$1.36M
SNOW icon
319
Snowflake
SNOW
$94.5B
$20.5M 0.04%
132,560
+18,795
+17% +$2.65M
ETN icon
320
Eaton
ETN
$150B
$20.5M 0.04%
61,627
+6,553
+12% +$2.3M
CFLT
321
DELISTED
Confluent
CFLT
$20.4M 0.04%
729,115
-62,653
-8% -$1.68M
CAG icon
322
Conagra Brands
CAG
$7.4B
$20.3M 0.04%
732,470
-40,159
-5% -$1.14M
GDYN icon
323
Grid Dynamics Holdings
GDYN
$516M
$20.2M 0.04%
+906,583
New +$15.8M
BG icon
324
Bunge Global
BG
$22.7B
$20M 0.04%
257,689
+11,841
+5% +$1.04M
TRV icon
325
Travelers Companies
TRV
$82.9B
$19.9M 0.04%
82,734
-4,838
-6% -$1.21M

Similar funds

Ensign Peak Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Ensign Peak Advisors held 1,743 positions worth $56.3B, down 1% from $56.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.1%. Ensign Peak Advisors opened 37 new positions and exited 34, leaving the 1,743-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 515,457 shares worth $302M.
  • Ensign Peak Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $156M increase.
  • Ensign Peak Advisors's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $374M.
  • Ensign Peak Advisors fully exited NewAmsterdam Pharma in Q4 2024, selling an estimated $4.08M.
  • Ensign Peak Advisors's ten largest holdings make up 32% of its $56.3B portfolio in Q4 2024.
  • Ensign Peak Advisors opened 37 new positions and closed 34 in Q4 2024.
  • Ensign Peak Advisors's portfolio value fell 1% quarter-over-quarter to $56.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.